Comments

Inozyme Pharma Stock Price, Quotes and Forecasts

Q: What sector and industry does Inozyme Pharma (INZY) operate in?

Inozyme Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

INZYNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Inozyme Pharma (INZY) Forecast

News Earnings Inozyme Pharma (INZY) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Inozyme Pharma Stock Price, Quotes and Forecasts | NASDAQ:INZY | Benzinga

Explore Inozyme Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for INZY.

Open	$1.01
Close	-
Volume / Avg.	321.25K / 705.82K
Day Range	$0.97 - $1.05
52 Wk Range	0.91 - 7.80
Market Cap	$63.26M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	7.38%
Days to Cover	7.28

Recent News

Why Analyst Says Rare Disease-Focused Inozyme Pharma Stock 'Could Be Worth A Look'

Stifel initiates coverage on Inozyme Pharma with a Buy rating and a $16 price target, highlighting INZ-701's potential to treat rare diseases like ENPP1 and ABCC6 deficiencies.

Vandana Singh

This AutoNation Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Avi Kapoor

Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Oct 24

Nov 24

Jan

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.01
Close	-
Volume / Avg.	321.25K / 705.82K
Day Range	$0.97 - $1.05
52 Wk Range	0.91 - 7.80
Market Cap	$63.26M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	7.38%
Days to Cover	7.28

About Inozyme Pharma Inc

Sector

Health Care

Industry

Biotechnology

Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for t...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Inozyme Pharma (INZY) stock?

You can purchase shares of Inozyme Pharma (NASDAQ:INZY) through any online brokerage.

View our list of the best stock brokerages

Who are Inozyme Pharma (INZY) competitors?

Other companies in Inozyme Pharma’s space includes: Skye Bioscience (NASDAQ:SKYE), CytomX Therapeutics (NASDAQ:CTMX), Gain Therapeutics (NASDAQ:GANX), Burning Rock Biotech (NASDAQ:BNR) and Immuneering (NASDAQ:IMRX).

What is the forecast, or price target, for Inozyme Pharma (INZY) stock?

Inozyme Pharma has a consensus price target of $15.91.

What is the current price for Inozyme Pharma (INZY)?

The stock price for Inozyme Pharma (NASDAQ: INZY) is $0.9848 last updated March 24, 2025 at 3:22 PM EDT.

Does Inozyme Pharma (INZY) pay a dividend?

There are no upcoming dividends for Inozyme Pharma.

When is Inozyme Pharma (NASDAQ:INZY) reporting earnings?

Inozyme Pharma’s Q1 earnings are confirmed for Tuesday, May 6, 2025.

Is Inozyme Pharma (INZY) going to split?

There is no upcoming split for Inozyme Pharma.

What sector and industry does Inozyme Pharma (INZY) operate in?

Inozyme Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.